Literature DB >> 7628393

Corticotropin release-inhibiting factor is preprothyrotropin-releasing hormone-(178-199).

E Redei1, H Hilderbrand, F Aird.   

Abstract

ACTH is the major regulator of the body's adaptive response to stress and the physiological stimulus for glucocorticoid secretion. In addition to the known negative feedback regulation of ACTH by glucocorticoids, a hypothalamic corticotropin release-inhibiting factor (CRIF) that inhibits ACTH synthesis and secretion has been postulated, but not identified. We previously reported that transfection of prepro-TRH complementary DNA into the mouse anterior pituitary tumor cell line AtT-20 results in inhibition of basal and corticotropin-releasing hormone (CRH)-stimulated ACTH synthesis and secretion, suggesting that one or more of the cryptic peptides encoded within the prepro-TRH precursor has CRIF activity. To narrow the choice of peptides responsible for CRIF activity, we first deleted specific sequences within the prepro-TRH complementary DNA and transfected these constructs into AtT-20 cells. Deletion of sequences encoding amino acids 119-229 resulted in the loss of CRIF activity. Of the peptides encoded within this region, prepro-TRH-(178-199), a 22-amino acid peptide, inhibited basal and CRH-stimulated ACTH synthesis and secretion in cultured primary anterior pituitary cells. As this peptide is processed from prepro-TRH in vivo, is found in the external zone of the median eminence, and is secreted from hypothalamic slices in vitro, prepro-TRH-(178-199) fulfills the criteria for a physiological CRIF. The significance of TRH and CRIF sharing a common precursor opens new areas of research in the integrated regulation of pituitary-adrenal and pituitary-thyroid functions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7628393     DOI: 10.1210/endo.136.8.7628393

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Inhibition of prolactin secretion from the male rat anterior pituitary by cryptic sequences of prothyrotropin releasing hormone, ProTRH178-199 and ProTRH186-199.

Authors:  Thomas H Alexander; Robert J Handa; Robert F McGivern
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

2.  Inhibition of stress-induced neuroendocrine and behavioral responses in the rat by prepro-thyrotropin-releasing hormone 178-199.

Authors:  R F McGivern; P Rittenhouse; F Aird; L D Van de Kar; E Redei
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

3.  Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene.

Authors:  M Yamada; Y Saga; N Shibusawa; J Hirato; M Murakami; T Iwasaki; K Hashimoto; T Satoh; K Wakabayashi; M M Taketo; M Mori
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

4.  Evidence for Neuropeptide W Acting as a Physiological Corticotropin-releasing Inhibitory Factor in Male Chickens.

Authors:  Meng Liu; Guixian Bu; Yiping Wan; Jiannan Zhang; Chunheng Mo; Juan Li; Yajun Wang
Journal:  Endocrinology       Date:  2022-07-01       Impact factor: 5.051

Review 5.  Thyrotropin-releasing hormone (TRH) in the cerebellum.

Authors:  Nobuyuki Shibusawa; Koshi Hashimoto; Masanobu Yamada
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.